Pharmacokinetics, Safety, and Tolerability of Lumateperone Long-Acting Injectable in Patients With Schizophrenia
Clinical trial NCT04709224 · COMPLETED
Trial details
- NCT number
- NCT04709224
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-30
- Primary completion
- 2022-05-23
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.